Corrigendum to "Stereocalpin A, a bioactive cyclic depsipeptide from the Antarctic lichen Stereocaulon alpinum" [Tetrahedron Lett. 49 (2008) 29] (DOI:10.1016/j.tetlet.2007.11.022);Stereocalpin A, a bioactive cyclic depsipeptide from the Antarctic lichen Stereocaulon alpinum

Tetrahedron Letters

Volumn 49, Issue 1, 2008, Pages 29-31

  Seo, Changon ^a   Yim, Joung Han ^b   Lee, Hong Kum ^b   Park, Seong Min ^c   Sohn, Jae Hak ^a   Oh, Hyuncheol ^a  

^a Silla University   (South Korea)

^b Korea Research Institute of Ships and Ocean Engineering   (South Korea)

^c Pukyong National University   (South Korea)

Author keywords

Cyclic depsipeptide; Cytotoxicity; Stereocalpin A; Stereocaulon alpinum

Indexed keywords

5 HYDROXY 2,4 DIMETHYL 3 OXOOCTANOIC ACID; CYCLOPEPTIDE; DEPSIPEPTIDE; METHANOL; OCTANOIC ACID DERIVATIVE; STEREOCALPIN A; UNCLASSIFIED DRUG;

ARTICLE; CHROMATOGRAPHY; DATA ANALYSIS; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG STRUCTURE; HUMAN; HUMAN CELL; LICHEN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SOLID TUMOR; STEREOCAULON ALPINUM; TUMOR CELL LINE;

STEREOCAULON ALPINUM;

EID: 36549014040     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2007.11.213     Document Type: Erratum

References (13)

1. Ingólfsdóttir K. Phytochemistry 61 (2002) 729
2. Kumar K.C.S., and Mu{combining double acute accent}ller K. J. Nat. Prod. 62 (1999) 817
3. Huneck S. Naturwissenschaften 86 (1999) 559
4. Ernst-Russell M.A., Chai C.L.L., Wardlaw J.H., and Elix J.A. J. Nat. Prod. 63 (2000) 129
5. 5Na, 515.2522).
6. Marfey P. Carlsberg Res. Commun. 49 (1984) 591
7. Oh D.-C., Kauffman C.A., Jensen P.R., and Fenical W. J. Nat. Prod. 70 (2007) 515
8. Hamaguchi T., Sudo T., and Osada H. FEBS Lett. 372 (1995) 54
9. Oh H., Kim B.S., Bae E.Y., Kim M.S., Kim B.Y., Lee H.B., Kim C.J., and Ahn J.S. J. Antibiot. 57 (2004) 528
10. Saltiel A.R., and Kahn C.R. Nature 414 (2001) 799
11. Johnson T.O., Ermolieff J., and Jirousek M.R. Nat. Rev. Drug. Discov. 1 (2002) 696
12. Dadke S., and Chernoff J. Curr. Drug Targets-Immune, Endocr. & Metabol. Disord. 3 (2003) 299
13. Tonks N.K. FEBS Lett. 546 (2003) 140